番茄社区

News, features, and commentary about cancer-related issues

New antibody indicated for previously treated, unresectable or metastatic HER2-positive disease

78% of patients in prospective study had tumor downstaging with immune checkpoint inhibitors

Trump's pick to lead HHS has called the mineral "industrial waste"

Patients with complete response can have long treatment-free interval, study suggests

More than 40% of adults, half of children met response criteria, majority of responses durable

News, features, and commentary about cancer-related issues

But absence of significant OS benefit raises questions about long-term benefit, expert says

Improvements seen in pain, neuropathy, and cognitive function

Delegates express concerns that PPE doesn't always cover women, who are more at risk of exposure

Health news and commentary gathered by 番茄社区 staff

And nearly half of responders to enfortumab vedotin plus pembrolizumab remained in remission

News, features, and commentary about cancer-related issues

Health news and commentary gathered by 番茄社区 staff